N-terminal pro-B-type natriuretic peptide, left ventricular mass, and incident heart failure: Multi-Ethnic Study of

Eui-Young Choi1, Hossein Bahrami, Colin O Wu

  • 1Johns Hopkins University, Baltimore, MD, USA.

Insights

Elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) predicts heart failure (HF) in asymptomatic individuals. NT-proBNP offers crucial prognostic information beyond traditional risk factors and LV mass index.

Area of Science:

  • Cardiology
  • Biomarkers
  • Preventive Medicine

Background:

  • Elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) is linked to overt heart failure (HF).
  • Prognostic value of NT-proBNP for incident HF in asymptomatic, multi-ethnic populations remains unclear.
  • The role of NT-proBNP alongside traditional risk factors and left ventricular (LV) mass index needs investigation.

Purpose of the Study:

  • To assess the association of plasma NT-proBNP and LV mass index with incident HF.
  • To determine if NT-proBNP provides additive prognostic value in asymptomatic individuals.
  • To evaluate these associations across diverse ethnic groups.

Main Methods:

  • Studied 5597 multi-ethnic asymptomatic participants without cardiovascular disease.
  • Measured baseline NT-proBNP and LV mass index (via cardiac MRI in 4163).
  • Followed participants for incident HF over 5.5 years.

Main Results:

  • Higher NT-proBNP levels significantly predicted incident HF, independent of numerous risk factors and LV mass index.
  • This association was consistent across non-Hispanic whites, African-Americans, and Hispanics.
  • NT-proBNP demonstrated significant additive prognostic value for incident HF prediction.

Conclusions:

  • Plasma NT-proBNP offers incremental prognostic information for incident symptomatic HF.
  • This value is significant beyond traditional risk factors and MRI-defined LV mass index.
  • NT-proBNP is a valuable biomarker for risk stratification in asymptomatic, multi-ethnic populations.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...